4.4 Article

Assessment of Selection Bias in Clinic-Based Populations of Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study

Journal

PEDIATRIC BLOOD & CANCER
Volume 52, Issue 3, Pages 379-386

Publisher

WILEY
DOI: 10.1002/pbc.21829

Keywords

epidemiology; late effects; long-term survival; outcomes research; pediatric oncology

Funding

  1. National Cancer Institute [CA 55727]
  2. American Lebanese Syrian Associated Charities (ALSAC)

Ask authors/readers for more resources

Background. It is not known to what extent prevalence estimates of late effects among childhood cancer survivors derived from clinic based samples represent file actual estimates that would he derived if the entire Population of childhood cancer survivors was recruited and evaluated for I particular Outcome. Procedure. In a large retrospective cohort study of childhood cancer survivors, the Childhood Cancer Survivor Study (CCSS), the prevalence of chronic health conditions among participants who reported being seen in a cancer center or long-term follow-up clinic was compared to the prevalence of chronic conditions in the entire cohort. Results. When compared 10 Survivors who had no medical care in the previous 2 years, Survivors accessing medical follow-Lip wore significantly more likely to have chronic health conditions. Relative risks of reporting a chronic health condition were 1.4 (95% CI: 1.3-1.5) if seen in a cancer center or long-term follow-up clinic and 1.2 (959% CI: 1.1-13) if seen in I general meclical care setting. Estimates derived from only those childhood cancer Survivors who were seen in a cancer center or long-term follow-up clinic overestimate the prevalence of any chronic disease by 9.3% (95% CI: 7.0-11.6). Conclusions. Applying chronic condition prevalence estimates from a clinical population to the general population of childhood cancer Survivors must be undertaken with caution. survivorship research must maintain a high level of scientific rigor to ensure that result,; reported in the literature are interpreted within the appropriate context. Pediatr Blood Cancer 2009;52:379-386. (C) 2008 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available